200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 178601-88-2

178601-88-2

178601-88-2 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-

CAS No: 178601-88-2 Catalog No: AG002661 MDL No:

Product Description

Catalog Number:
AG002661
Chemical Name:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-
CAS Number:
178601-88-2
Molecular Formula:
C14H13N5O5S2
Molecular Weight:
395.4135
IUPAC Name:
(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI:
InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7+/t8-,12-/m1/s1
InChI Key:
RTXOFQZKPXMALH-RWFJUVPESA-N
SMILES:
O/N=C(\c1csc(n1)N)/C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)C=C
UNII:
61G2M33IGF

Properties

Complexity:
739  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
1  
Exact Mass:
395.036g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
395.408g/mol
Monoisotopic Mass:
395.036g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
212A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0

Literature

Title Journal
Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs 20121022
Development and validation of a rapid HPLC method for the determination of cefdinir in beagle dog plasma integrated with an automatic on-line solid-phase extraction following protein precipitation in the 96-well plate format. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
[Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy]. Yao xue xue bao = Acta pharmaceutica Sinica 20120401
Bioequivalence evaluation of cefdinir in healthy fasting subjects. Arzneimittel-Forschung 20120101
Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815
Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms. Scandinavian journal of infectious diseases 20110801
Prophylactic cefdinir for pediatric cases of complicated urinary tract infection. Pediatrics international : official journal of the Japan Pediatric Society 20110201
Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process. International journal of pharmaceutics 20100830
Another vacation, another medical 'crisis'. Nature reviews. Gastroenterology & hepatology 20100401
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections. The Japanese journal of antibiotics 20100201
Infant male with blood-colored stools. Annals of emergency medicine 20090801
Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. International journal of pediatric otorhinolaryngology 20090501
Visual diagnosis: four infants who have red, 'bloody' stools. Pediatrics in review 20090401
Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. Journal of general internal medicine 20081101
Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080801
Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. Journal of pharmaceutical and biomedical analysis 20080715
Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas. Pharmacotherapy 20080501
A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder. Journal of paediatrics and child health 20080401
Voltammetric behavior of cefdinir in solubilized system. Journal of colloid and interface science 20080215
Cefdinir-associated 'bloody stools' in an infant. Journal of the American Board of Family Medicine : JABFM 20080101
Comparative bioavailability of two cefdinir suspension formulations in Middle Eastern healthy volunteers after single oral administration. Arzneimittel-Forschung 20080101
Effect of L-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study. Journal of clinical pharmacy and therapeutics 20070601
Isolation, structural elucidation and characterization of impurities in Cefdinir. Journal of pharmaceutical and biomedical analysis 20070312
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. Expert review of anti-infective therapy 20070201
Bayesian estimation of intervention effect with pre- and post-misclassified binomial data. Journal of biopharmaceutical statistics 20070101
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults. Current medical research and opinion 20061201
Therapeutic experience with cefdinir in the treatment of uSSSIs. International journal of clinical practice 20061001
Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20061001
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children. Current medical research and opinion 20060901
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly? Diagnostic microbiology and infectious disease 20060801
The efficacy of cefdinir in acute bacterial rhinosinusitis. Expert opinion on pharmacotherapy 20060601
Selective method for the determination of cefdinir in human plasma using liquid chromatography electrospray ionization tandam mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060413
Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily. The Pediatric infectious disease journal 20060301
A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. The Pediatric infectious disease journal 20060301
Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20060101
Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid. Pharmacotherapy 20051201
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. Clinical therapeutics 20051201
Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora. Archives of otolaryngology--head & neck surgery 20050901
A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis. Clinical therapeutics 20050801
Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate. Journal of medical microbiology 20050601
A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. Clinical therapeutics 20050601
Cefdinir: an oral alternative to parenteral cephems. Diagnostic microbiology and infectious disease 20050401
[Effects of cefdinir in pediatric infectious diseases]. Zhonghua er ke za zhi = Chinese journal of pediatrics 20050301
Estimation of the intervention effect in a non-randomized study with pre- and post-mismeasured binary responses. Statistics in medicine 20050215
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections. International journal of antimicrobial agents 20050101
Determination of Cefdinir by a stability-indicating liquid chromatographic method. Journal of AOAC International 20050101
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. Clinical therapeutics 20041201
[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]. Zhonghua yi xue za zhi 20041117
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia]. Zhonghua yi xue za zhi 20041117
Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media. The Pediatric infectious disease journal 20040901
[In vitro antibacterial activity of cefdinir against isolates of respiratory tract pathogens in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics 20040901
Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear. The Pediatric infectious disease journal 20040801
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates. Diagnostic microbiology and infectious disease 20040801
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections. Cutis 20040501
Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes. Biological & pharmaceutical bulletin 20040101
Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs 20040101
Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions. Paediatric drugs 20040101
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002). Diagnostic microbiology and infectious disease 20031101
[Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis]. The Japanese journal of antibiotics 20030801
An alternative procedure for preparation of cefdinir. Farmaco (Societa chimica italiana : 1989) 20030601
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs]. The Japanese journal of antibiotics 20030601
Management update of acute bacterial rhinosinusitis and the use of cefdinir. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20021201
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002]. The Japanese journal of antibiotics 20021201
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001]. The Japanese journal of antibiotics 20021201
Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. Clinical therapeutics 20020401
Antibacterial action of several tannins against Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20011001
Evaluation of oral antimicrobial agent levels in tooth extraction sites. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010601
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (5)--Six-month repeated oral dose toxicity study and supplement study in rats]. The Journal of toxicological sciences 20010501
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20010301
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. Internal medicine (Tokyo, Japan) 20010201

© 2019 Angene International Limited. All rights Reserved.